The global market for Antifungal infection Therapeutics was valued at US$ 21090 million in the year 2024 and is projected to reach a revised size of US$ 33130 million by 2031, growing at a CAGR of 6.8% during the forecast period.

Antifungal infection Therapeutics Market

Antifungal drugs are used to treat infections caused by fungus and to prevent the development of fungal infections in patients with weakened immune systems.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Antifungal infection Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antifungal infection Therapeutics.

The Antifungal infection Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Antifungal infection Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Antifungal infection Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Antifungal infection Therapeutics Market Report

Report Metric	Details
Report Name	Antifungal infection Therapeutics Market
Accounted market size in year	US$ 21090 million
Forecasted market size in 2031	US$ 33130 million
CAGR	6.8%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Polyenes Echinocandins Azoles Allylamines Other Drug types
Segment by Application	Hospitals and Clinics Dermatology Clinic
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Scynexis, Sanofi-Aventis, Pfizer, Novartis, Merck & Co, Kramer Laboratories, Johnson & Johnson, ID Sigma-Aldrich Corporation, Glenmark Pharmaceuticals, Glaxosmithkline, Enzon Pharmaceuticals, Bayer Healthcare, Astellas Pharma, Asperqillus, Alternaria, Abbott Laboratories
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Antifungal infection Therapeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Antifungal infection Therapeutics Market growing?

Ans: The Antifungal infection Therapeutics Market witnessing a CAGR of 6.8% during the forecast period 2025-2031.

What is the Antifungal infection Therapeutics Market size in 2031?

Ans: The Antifungal infection Therapeutics Market size in 2031 will be US$ 33130 million.

Who are the main players in the Antifungal infection Therapeutics Market report?

Ans: The main players in the Antifungal infection Therapeutics Market are Scynexis, Sanofi-Aventis, Pfizer, Novartis, Merck & Co, Kramer Laboratories, Johnson & Johnson, ID Sigma-Aldrich Corporation, Glenmark Pharmaceuticals, Glaxosmithkline, Enzon Pharmaceuticals, Bayer Healthcare, Astellas Pharma, Asperqillus, Alternaria, Abbott Laboratories

What are the Application segmentation covered in the Antifungal infection Therapeutics Market report?

Ans: The Applications covered in the Antifungal infection Therapeutics Market report are Hospitals and Clinics, Dermatology Clinic

What are the Type segmentation covered in the Antifungal infection Therapeutics Market report?

Ans: The Types covered in the Antifungal infection Therapeutics Market report are Polyenes, Echinocandins, Azoles, Allylamines, Other Drug types

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Antifungal infection Therapeutics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Polyenes

1.2.3 Echinocandins

1.2.4 Azoles

1.2.5 Allylamines

1.2.6 Other Drug types

1.3 Market by Application

1.3.1 Global Antifungal infection Therapeutics Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospitals and Clinics

1.3.3 Dermatology Clinic

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Antifungal infection Therapeutics Market Perspective (2020-2031)

2.2 Global Antifungal infection Therapeutics Growth Trends by Region

2.2.1 Global Antifungal infection Therapeutics Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Antifungal infection Therapeutics Historic Market Size by Region (2020-2025)

2.2.3 Antifungal infection Therapeutics Forecasted Market Size by Region (2026-2031)

2.3 Antifungal infection Therapeutics Market Dynamics

2.3.1 Antifungal infection Therapeutics Industry Trends

2.3.2 Antifungal infection Therapeutics Market Drivers

2.3.3 Antifungal infection Therapeutics Market Challenges

2.3.4 Antifungal infection Therapeutics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Antifungal infection Therapeutics Players by Revenue

3.1.1 Global Top Antifungal infection Therapeutics Players by Revenue (2020-2025)

3.1.2 Global Antifungal infection Therapeutics Revenue Market Share by Players (2020-2025)

3.2 Global Antifungal infection Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Antifungal infection Therapeutics Revenue

3.4 Global Antifungal infection Therapeutics Market Concentration Ratio

3.4.1 Global Antifungal infection Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Antifungal infection Therapeutics Revenue in 2024

3.5 Global Key Players of Antifungal infection Therapeutics Head office and Area Served

3.6 Global Key Players of Antifungal infection Therapeutics, Product and Application

3.7 Global Key Players of Antifungal infection Therapeutics, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Antifungal infection Therapeutics Breakdown Data by Type

4.1 Global Antifungal infection Therapeutics Historic Market Size by Type (2020-2025)

4.2 Global Antifungal infection Therapeutics Forecasted Market Size by Type (2026-2031)

5 Antifungal infection Therapeutics Breakdown Data by Application

5.1 Global Antifungal infection Therapeutics Historic Market Size by Application (2020-2025)

5.2 Global Antifungal infection Therapeutics Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Antifungal infection Therapeutics Market Size (2020-2031)

6.2 North America Antifungal infection Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Antifungal infection Therapeutics Market Size by Country (2020-2025)

6.4 North America Antifungal infection Therapeutics Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Antifungal infection Therapeutics Market Size (2020-2031)

7.2 Europe Antifungal infection Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Antifungal infection Therapeutics Market Size by Country (2020-2025)

7.4 Europe Antifungal infection Therapeutics Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Antifungal infection Therapeutics Market Size (2020-2031)

8.2 Asia-Pacific Antifungal infection Therapeutics Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Antifungal infection Therapeutics Market Size by Region (2020-2025)

8.4 Asia-Pacific Antifungal infection Therapeutics Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Antifungal infection Therapeutics Market Size (2020-2031)

9.2 Latin America Antifungal infection Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Antifungal infection Therapeutics Market Size by Country (2020-2025)

9.4 Latin America Antifungal infection Therapeutics Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Antifungal infection Therapeutics Market Size (2020-2031)

10.2 Middle East & Africa Antifungal infection Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Antifungal infection Therapeutics Market Size by Country (2020-2025)

10.4 Middle East & Africa Antifungal infection Therapeutics Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Scynexis

11.1.1 Scynexis Company Details

11.1.2 Scynexis Business Overview

11.1.3 Scynexis Antifungal infection Therapeutics Introduction

11.1.4 Scynexis Revenue in Antifungal infection Therapeutics Business (2020-2025)

11.1.5 Scynexis Recent Development

11.2 Sanofi-Aventis

11.2.1 Sanofi-Aventis Company Details

11.2.2 Sanofi-Aventis Business Overview

11.2.3 Sanofi-Aventis Antifungal infection Therapeutics Introduction

11.2.4 Sanofi-Aventis Revenue in Antifungal infection Therapeutics Business (2020-2025)

11.2.5 Sanofi-Aventis Recent Development

11.3 Pfizer

11.3.1 Pfizer Company Details

11.3.2 Pfizer Business Overview

11.3.3 Pfizer Antifungal infection Therapeutics Introduction

11.3.4 Pfizer Revenue in Antifungal infection Therapeutics Business (2020-2025)

11.3.5 Pfizer Recent Development

11.4 Novartis

11.4.1 Novartis Company Details

11.4.2 Novartis Business Overview

11.4.3 Novartis Antifungal infection Therapeutics Introduction

11.4.4 Novartis Revenue in Antifungal infection Therapeutics Business (2020-2025)

11.4.5 Novartis Recent Development

11.5 Merck & Co

11.5.1 Merck & Co Company Details

11.5.2 Merck & Co Business Overview

11.5.3 Merck & Co Antifungal infection Therapeutics Introduction

11.5.4 Merck & Co Revenue in Antifungal infection Therapeutics Business (2020-2025)

11.5.5 Merck & Co Recent Development

11.6 Kramer Laboratories

11.6.1 Kramer Laboratories Company Details

11.6.2 Kramer Laboratories Business Overview

11.6.3 Kramer Laboratories Antifungal infection Therapeutics Introduction

11.6.4 Kramer Laboratories Revenue in Antifungal infection Therapeutics Business (2020-2025)

11.6.5 Kramer Laboratories Recent Development

11.7 Johnson & Johnson

11.7.1 Johnson & Johnson Company Details

11.7.2 Johnson & Johnson Business Overview

11.7.3 Johnson & Johnson Antifungal infection Therapeutics Introduction

11.7.4 Johnson & Johnson Revenue in Antifungal infection Therapeutics Business (2020-2025)

11.7.5 Johnson & Johnson Recent Development

11.8 ID Sigma-Aldrich Corporation

11.8.1 ID Sigma-Aldrich Corporation Company Details

11.8.2 ID Sigma-Aldrich Corporation Business Overview

11.8.3 ID Sigma-Aldrich Corporation Antifungal infection Therapeutics Introduction

11.8.4 ID Sigma-Aldrich Corporation Revenue in Antifungal infection Therapeutics Business (2020-2025)

11.8.5 ID Sigma-Aldrich Corporation Recent Development

11.9 Glenmark Pharmaceuticals

11.9.1 Glenmark Pharmaceuticals Company Details

11.9.2 Glenmark Pharmaceuticals Business Overview

11.9.3 Glenmark Pharmaceuticals Antifungal infection Therapeutics Introduction

11.9.4 Glenmark Pharmaceuticals Revenue in Antifungal infection Therapeutics Business (2020-2025)

11.9.5 Glenmark Pharmaceuticals Recent Development

11.10 Glaxosmithkline

11.10.1 Glaxosmithkline Company Details

11.10.2 Glaxosmithkline Business Overview

11.10.3 Glaxosmithkline Antifungal infection Therapeutics Introduction

11.10.4 Glaxosmithkline Revenue in Antifungal infection Therapeutics Business (2020-2025)

11.10.5 Glaxosmithkline Recent Development

11.11 Enzon Pharmaceuticals

11.11.1 Enzon Pharmaceuticals Company Details

11.11.2 Enzon Pharmaceuticals Business Overview

11.11.3 Enzon Pharmaceuticals Antifungal infection Therapeutics Introduction

11.11.4 Enzon Pharmaceuticals Revenue in Antifungal infection Therapeutics Business (2020-2025)

11.11.5 Enzon Pharmaceuticals Recent Development

11.12 Bayer Healthcare

11.12.1 Bayer Healthcare Company Details

11.12.2 Bayer Healthcare Business Overview

11.12.3 Bayer Healthcare Antifungal infection Therapeutics Introduction

11.12.4 Bayer Healthcare Revenue in Antifungal infection Therapeutics Business (2020-2025)

11.12.5 Bayer Healthcare Recent Development

11.13 Astellas Pharma

11.13.1 Astellas Pharma Company Details

11.13.2 Astellas Pharma Business Overview

11.13.3 Astellas Pharma Antifungal infection Therapeutics Introduction

11.13.4 Astellas Pharma Revenue in Antifungal infection Therapeutics Business (2020-2025)

11.13.5 Astellas Pharma Recent Development

11.14 Asperqillus

11.14.1 Asperqillus Company Details

11.14.2 Asperqillus Business Overview

11.14.3 Asperqillus Antifungal infection Therapeutics Introduction

11.14.4 Asperqillus Revenue in Antifungal infection Therapeutics Business (2020-2025)

11.14.5 Asperqillus Recent Development

11.15 Alternaria

11.15.1 Alternaria Company Details

11.15.2 Alternaria Business Overview

11.15.3 Alternaria Antifungal infection Therapeutics Introduction

11.15.4 Alternaria Revenue in Antifungal infection Therapeutics Business (2020-2025)

11.15.5 Alternaria Recent Development

11.16 Abbott Laboratories

11.16.1 Abbott Laboratories Company Details

11.16.2 Abbott Laboratories Business Overview

11.16.3 Abbott Laboratories Antifungal infection Therapeutics Introduction

11.16.4 Abbott Laboratories Revenue in Antifungal infection Therapeutics Business (2020-2025)

11.16.5 Abbott Laboratories Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

ID Sigma-Aldrich Corporation

Glenmark Pharmaceuticals

GlaxoSmithKline PLC

Enzon Pharmaceuticals

List of Tables

Table 1. Global Antifungal infection Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Polyenes

Table 3. Key Players of Echinocandins

Table 4. Key Players of Azoles

Table 5. Key Players of Allylamines

Table 6. Key Players of Other Drug types

Table 7. Global Antifungal infection Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Antifungal infection Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 9. Global Antifungal infection Therapeutics Market Size by Region (2020-2025) & (US$ Million)

Table 10. Global Antifungal infection Therapeutics Market Share by Region (2020-2025)

Table 11. Global Antifungal infection Therapeutics Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 12. Global Antifungal infection Therapeutics Market Share by Region (2026-2031)

Table 13. Antifungal infection Therapeutics Market Trends

Table 14. Antifungal infection Therapeutics Market Drivers

Table 15. Antifungal infection Therapeutics Market Challenges

Table 16. Antifungal infection Therapeutics Market Restraints

Table 17. Global Antifungal infection Therapeutics Revenue by Players (2020-2025) & (US$ Million)

Table 18. Global Antifungal infection Therapeutics Market Share by Players (2020-2025)

Table 19. Global Top Antifungal infection Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antifungal infection Therapeutics as of 2024)

Table 20. Ranking of Global Top Antifungal infection Therapeutics Companies by Revenue (US$ Million) in 2024

Table 21. Global 5 Largest Players Market Share by Antifungal infection Therapeutics Revenue (CR5 and HHI) & (2020-2025)

Table 22. Global Key Players of Antifungal infection Therapeutics, Headquarters and Area Served

Table 23. Global Key Players of Antifungal infection Therapeutics, Product and Application

Table 24. Global Key Players of Antifungal infection Therapeutics, Date of Enter into This Industry

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Antifungal infection Therapeutics Market Size by Type (2020-2025) & (US$ Million)

Table 27. Global Antifungal infection Therapeutics Revenue Market Share by Type (2020-2025)

Table 28. Global Antifungal infection Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 29. Global Antifungal infection Therapeutics Revenue Market Share by Type (2026-2031)

Table 30. Global Antifungal infection Therapeutics Market Size by Application (2020-2025) & (US$ Million)

Table 31. Global Antifungal infection Therapeutics Revenue Market Share by Application (2020-2025)

Table 32. Global Antifungal infection Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 33. Global Antifungal infection Therapeutics Revenue Market Share by Application (2026-2031)

Table 34. North America Antifungal infection Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. North America Antifungal infection Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 36. North America Antifungal infection Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 37. Europe Antifungal infection Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 38. Europe Antifungal infection Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 39. Europe Antifungal infection Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 40. Asia-Pacific Antifungal infection Therapeutics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 41. Asia-Pacific Antifungal infection Therapeutics Market Size by Region (2020-2025) & (US$ Million)

Table 42. Asia-Pacific Antifungal infection Therapeutics Market Size by Region (2026-2031) & (US$ Million)

Table 43. Latin America Antifungal infection Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Latin America Antifungal infection Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 45. Latin America Antifungal infection Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 46. Middle East & Africa Antifungal infection Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 47. Middle East & Africa Antifungal infection Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 48. Middle East & Africa Antifungal infection Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 49. Scynexis Company Details

Table 50. Scynexis Business Overview

Table 51. Scynexis Antifungal infection Therapeutics Product

Table 52. Scynexis Revenue in Antifungal infection Therapeutics Business (2020-2025) & (US$ Million)

Table 53. Scynexis Recent Development

Table 54. Sanofi-Aventis Company Details

Table 55. Sanofi-Aventis Business Overview

Table 56. Sanofi-Aventis Antifungal infection Therapeutics Product

Table 57. Sanofi-Aventis Revenue in Antifungal infection Therapeutics Business (2020-2025) & (US$ Million)

Table 58. Sanofi-Aventis Recent Development

Table 59. Pfizer Company Details

Table 60. Pfizer Business Overview

Table 61. Pfizer Antifungal infection Therapeutics Product

Table 62. Pfizer Revenue in Antifungal infection Therapeutics Business (2020-2025) & (US$ Million)

Table 63. Pfizer Recent Development

Table 64. Novartis Company Details

Table 65. Novartis Business Overview

Table 66. Novartis Antifungal infection Therapeutics Product

Table 67. Novartis Revenue in Antifungal infection Therapeutics Business (2020-2025) & (US$ Million)

Table 68. Novartis Recent Development

Table 69. Merck & Co Company Details

Table 70. Merck & Co Business Overview

Table 71. Merck & Co Antifungal infection Therapeutics Product

Table 72. Merck & Co Revenue in Antifungal infection Therapeutics Business (2020-2025) & (US$ Million)

Table 73. Merck & Co Recent Development

Table 74. Kramer Laboratories Company Details

Table 75. Kramer Laboratories Business Overview

Table 76. Kramer Laboratories Antifungal infection Therapeutics Product

Table 77. Kramer Laboratories Revenue in Antifungal infection Therapeutics Business (2020-2025) & (US$ Million)

Table 78. Kramer Laboratories Recent Development

Table 79. Johnson & Johnson Company Details

Table 80. Johnson & Johnson Business Overview

Table 81. Johnson & Johnson Antifungal infection Therapeutics Product

Table 82. Johnson & Johnson Revenue in Antifungal infection Therapeutics Business (2020-2025) & (US$ Million)

Table 83. Johnson & Johnson Recent Development

Table 84. ID Sigma-Aldrich Corporation Company Details

Table 85. ID Sigma-Aldrich Corporation Business Overview

Table 86. ID Sigma-Aldrich Corporation Antifungal infection Therapeutics Product

Table 87. ID Sigma-Aldrich Corporation Revenue in Antifungal infection Therapeutics Business (2020-2025) & (US$ Million)

Table 88. ID Sigma-Aldrich Corporation Recent Development

Table 89. Glenmark Pharmaceuticals Company Details

Table 90. Glenmark Pharmaceuticals Business Overview

Table 91. Glenmark Pharmaceuticals Antifungal infection Therapeutics Product

Table 92. Glenmark Pharmaceuticals Revenue in Antifungal infection Therapeutics Business (2020-2025) & (US$ Million)

Table 93. Glenmark Pharmaceuticals Recent Development

Table 94. Glaxosmithkline Company Details

Table 95. Glaxosmithkline Business Overview

Table 96. Glaxosmithkline Antifungal infection Therapeutics Product

Table 97. Glaxosmithkline Revenue in Antifungal infection Therapeutics Business (2020-2025) & (US$ Million)

Table 98. Glaxosmithkline Recent Development

Table 99. Enzon Pharmaceuticals Company Details

Table 100. Enzon Pharmaceuticals Business Overview

Table 101. Enzon Pharmaceuticals Antifungal infection Therapeutics Product

Table 102. Enzon Pharmaceuticals Revenue in Antifungal infection Therapeutics Business (2020-2025) & (US$ Million)

Table 103. Enzon Pharmaceuticals Recent Development

Table 104. Bayer Healthcare Company Details

Table 105. Bayer Healthcare Business Overview

Table 106. Bayer Healthcare Antifungal infection Therapeutics Product

Table 107. Bayer Healthcare Revenue in Antifungal infection Therapeutics Business (2020-2025) & (US$ Million)

Table 108. Bayer Healthcare Recent Development

Table 109. Astellas Pharma Company Details

Table 110. Astellas Pharma Business Overview

Table 111. Astellas Pharma Antifungal infection Therapeutics Product

Table 112. Astellas Pharma Revenue in Antifungal infection Therapeutics Business (2020-2025) & (US$ Million)

Table 113. Astellas Pharma Recent Development

Table 114. Asperqillus Company Details

Table 115. Asperqillus Business Overview

Table 116. Asperqillus Antifungal infection Therapeutics Product

Table 117. Asperqillus Revenue in Antifungal infection Therapeutics Business (2020-2025) & (US$ Million)

Table 118. Asperqillus Recent Development

Table 119. Alternaria Company Details

Table 120. Alternaria Business Overview

Table 121. Alternaria Antifungal infection Therapeutics Product

Table 122. Alternaria Revenue in Antifungal infection Therapeutics Business (2020-2025) & (US$ Million)

Table 123. Alternaria Recent Development

Table 124. Abbott Laboratories Company Details

Table 125. Abbott Laboratories Business Overview

Table 126. Abbott Laboratories Antifungal infection Therapeutics Product

Table 127. Abbott Laboratories Revenue in Antifungal infection Therapeutics Business (2020-2025) & (US$ Million)

Table 128. Abbott Laboratories Recent Development

Table 129. Research Programs/Design for This Report

Table 130. Key Data Information from Secondary Sources

Table 131. Key Data Information from Primary Sources

Table 132. Authors List of This Report

List of Figures

Figure 1. Antifungal infection Therapeutics Picture

Figure 2. Global Antifungal infection Therapeutics Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Antifungal infection Therapeutics Market Share by Type: 2024 VS 2031

Figure 4. Polyenes Features

Figure 5. Echinocandins Features

Figure 6. Azoles Features

Figure 7. Allylamines Features

Figure 8. Other Drug types Features

Figure 9. Global Antifungal infection Therapeutics Market Size by Application (2020-2031) & (US$ Million)

Figure 10. Global Antifungal infection Therapeutics Market Share by Application: 2024 VS 2031

Figure 11. Hospitals and Clinics Case Studies

Figure 12. Dermatology Clinic Case Studies

Figure 13. Antifungal infection Therapeutics Report Years Considered

Figure 14. Global Antifungal infection Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 15. Global Antifungal infection Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 16. Global Antifungal infection Therapeutics Market Share by Region: 2024 VS 2031

Figure 17. Global Antifungal infection Therapeutics Market Share by Players in 2024

Figure 18. Global Top Antifungal infection Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antifungal infection Therapeutics as of 2024)

Figure 19. The Top 10 and 5 Players Market Share by Antifungal infection Therapeutics Revenue in 2024

Figure 20. North America Antifungal infection Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. North America Antifungal infection Therapeutics Market Share by Country (2020-2031)

Figure 22. United States Antifungal infection Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Canada Antifungal infection Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Antifungal infection Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Antifungal infection Therapeutics Market Share by Country (2020-2031)

Figure 26. Germany Antifungal infection Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. France Antifungal infection Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. U.K. Antifungal infection Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Italy Antifungal infection Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Russia Antifungal infection Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Nordic Countries Antifungal infection Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Antifungal infection Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Antifungal infection Therapeutics Market Share by Region (2020-2031)

Figure 34. China Antifungal infection Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Japan Antifungal infection Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. South Korea Antifungal infection Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Southeast Asia Antifungal infection Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. India Antifungal infection Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Australia Antifungal infection Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Antifungal infection Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Antifungal infection Therapeutics Market Share by Country (2020-2031)

Figure 42. Mexico Antifungal infection Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Brazil Antifungal infection Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Antifungal infection Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Antifungal infection Therapeutics Market Share by Country (2020-2031)

Figure 46. Turkey Antifungal infection Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Saudi Arabia Antifungal infection Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. UAE Antifungal infection Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Scynexis Revenue Growth Rate in Antifungal infection Therapeutics Business (2020-2025)

Figure 50. Sanofi-Aventis Revenue Growth Rate in Antifungal infection Therapeutics Business (2020-2025)

Figure 51. Pfizer Revenue Growth Rate in Antifungal infection Therapeutics Business (2020-2025)

Figure 52. Novartis Revenue Growth Rate in Antifungal infection Therapeutics Business (2020-2025)

Figure 53. Merck & Co Revenue Growth Rate in Antifungal infection Therapeutics Business (2020-2025)

Figure 54. Kramer Laboratories Revenue Growth Rate in Antifungal infection Therapeutics Business (2020-2025)

Figure 55. Johnson & Johnson Revenue Growth Rate in Antifungal infection Therapeutics Business (2020-2025)

Figure 56. ID Sigma-Aldrich Corporation Revenue Growth Rate in Antifungal infection Therapeutics Business (2020-2025)

Figure 57. Glenmark Pharmaceuticals Revenue Growth Rate in Antifungal infection Therapeutics Business (2020-2025)

Figure 58. Glaxosmithkline Revenue Growth Rate in Antifungal infection Therapeutics Business (2020-2025)

Figure 59. Enzon Pharmaceuticals Revenue Growth Rate in Antifungal infection Therapeutics Business (2020-2025)

Figure 60. Bayer Healthcare Revenue Growth Rate in Antifungal infection Therapeutics Business (2020-2025)

Figure 61. Astellas Pharma Revenue Growth Rate in Antifungal infection Therapeutics Business (2020-2025)

Figure 62. Asperqillus Revenue Growth Rate in Antifungal infection Therapeutics Business (2020-2025)

Figure 63. Alternaria Revenue Growth Rate in Antifungal infection Therapeutics Business (2020-2025)

Figure 64. Abbott Laboratories Revenue Growth Rate in Antifungal infection Therapeutics Business (2020-2025)

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions